SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer

by Luwei Han, Xiaomeng Zhang, Zhiqiang Wang, Xian Zhang, Liwen Zhao, Wei Fu, Xiaobo Liang, Zhibo Zhang, Yong Wang
Published 2021-04-01

Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China

by Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, Dezhen Peng, Danyu Du, Xian Zhang, Luwei Han, Liwen Zhao, Ligong Lu, Hongzhi Du, Shengtao Yuan, Meixiao Zhan
Published 2021-06-01